NH
NHI.US National Health Investors Inc
- Market cap
- USD 2.98B
- P/E
- 4.4x
- P/B
- 1.48x
- ROE
- 42.1%
- Dividend yield
- 5.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NHI.US undervalued?
Graham numberNHI.US trades 46.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
National Health Investors Inc fundamental analysis
No fundamental analysis for National Health Investors Inc yet.
National Health Investors Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About National Health Investors Inc
National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company's real estate property investments include independent living facilities, assisted living facilities, en…
Full company profileNational Health Investors Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
National Health Investors Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 249M | 279M | 295M | 318M | 333M | 299M | 278M | 320M | 335M | 379M | 468M |
| Gross Profit | 247M | 278M | 293M | 312M | 323M | 287M | 268M | 308M | 324M | 139M | 261M |
| Operating Income | 178M | 198M | 209M | 220M | 225M | 185M | 133M | 179M | 184M | 195M | 176M |
| EBITDA | 256M | 269M | 271M | 291M | 318M | 241M | 179M | 260M | 264M | 282M | 1.04B |
| Net Income | 152M | 159M | 154M | 160M | 185M | 112M | 66.4M | 136M | 138M | 142M | 879M |
| EPS | 3.87 | 3.87 | 3.67 | 3.67 | 4.14 | 2.44 | 1.48 | 3.13 | 3.13 | 3.02 | 18 |
| Balance Sheet | |||||||||||
| Total Assets | 2.40B | 2.55B | 2.75B | 3.04B | 3.12B | 2.84B | 2.51B | 2.49B | 2.61B | 2.80B | 3.24B |
| Total Liabilities | 1.19B | 1.22B | 1.36B | 1.54B | 1.60B | 1.32B | 1.22B | 1.21B | 1.23B | 1.26B | 1.14B |
| Shareholders' Equity | 1.21B | 1.32B | 1.39B | 1.50B | 1.52B | 1.52B | 1.29B | 1.25B | 1.37B | 1.52B | 2.09B |
| Cash & Short-term Investments | 4.83M | 3.06M | 4.66M | 5.22M | 43.3M | 37.4M | 19.3M | 22.3M | 24.3M | 19.6M | 46.6M |
| Total Debt | 1.14B | 1.17B | 1.30B | 1.44B | 1.96B | 1.32B | 1.56B | 1.14B | 1.15B | 1.16B | 1.04B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 177M | 197M | 208M | 241M | 232M | 211M | 185M | 184M | 208M | 240M | 222M |
| Capital Expenditure | 367M | 175M | 148M | 237M | 103M | 64.0K | 6.36M | 3.74M | 15.7M | 20.0M | 24.0M |
| Free Cash Flow | -190M | 22.0M | 60.2M | 3.77M | 129M | 211M | 179M | 181M | 192M | 220M | 198M |
| Ratios | |||||||||||
| ROE | 12.5% | 12.1% | 11.1% | 10.7% | 12.2% | 7.4% | 5.1% | 10.8% | 10.1% | 9.3% | 42.1% |
| ROA | 6.3% | 6.3% | 5.6% | 5.3% | 5.9% | 3.9% | 2.6% | 5.5% | 5.3% | 5.1% | 27.1% |
| Net Profit Margin | 61.0% | 57.2% | 52.4% | 50.4% | 55.6% | 37.4% | 23.9% | 42.4% | 41.2% | 37.6% | 188.0% |
| Debt to Equity | 0.94x | 0.88x | 0.94x | 0.96x | 1.29x | 0.87x | 1.21x | 0.91x | 0.84x | 0.76x | 0.50x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
National Health Investors Inc dividends
- Dividend yield
- 5.69%
- Forward dividend
- 3.76 USD
- Payout ratio
- 119.4%
- Ex-dividend date
- Dec 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 170M | 3.61 | 119.4% |
| 2024 | USD 157M | 3.55 | 113.4% |
| 2023 | USD 156M | 3.60 | 115.2% |
| 2022 | USD 162M | 3.61 | 243.6% |
| 2021 | USD 183M | 4.00 | 163.6% |
| 2020 | USD 195M | 4.35 | 105.1% |
| 2019 | USD 180M | 4.11 | 112.0% |
| 2018 | USD 165M | 3.93 | 107.2% |
| 2017 | USD 153M | 3.72 | 96.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns National Health Investors Inc
- Insiders 3.55%
- Institutions 79.68%
- Public & others 16.77%
- Shares outstanding 49.1M
- Free float 47.9M
Top funds holding NHI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2.96M | 6.02% | +0.05% | Oct 2026 |
| Vanguard Real Estate Index Investor | 1.79M | 3.64% | +0.71% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.58M | 3.21% | +7.65% | Sep 2026 |
| iShares Russell 2000 ETF | 1.23M | 2.51% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 1.10M | 2.25% | +4.24% | Sep 2026 |
| Principal Real Estate Securities R5 | 878K | 1.79% | +4.50% | Sep 2026 |
| BNY Mellon Global Infras Inc ETF | 825K | 1.68% | -0.76% | Oct 2026 |
| Vanguard MStar Small Cap Value Index | 719K | 1.47% | +6.93% | Sep 2026 |
| Fidelity Small Cap Index | 536K | 1.09% | +0.15% | Aug 2026 |
| iShares Russell 2000 Value ETF | 460K | 0.94% | 0.00% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 450K | 0.92% | -0.05% | Oct 2026 |
| Schwab US REIT ETF™ | 389K | 0.79% | +0.21% | Oct 2026 |
| Nomura Small Cap Value A | 375K | 0.76% | 0.00% | Sep 2026 |
| Vanguard Real Estate II Index | 317K | 0.65% | +0.72% | Sep 2026 |
| DFA Real Estate Securities I | 309K | 0.63% | +29.91% | Sep 2026 |
| Vanguard Russell 2000 ETF | 283K | 0.58% | +1.15% | Sep 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 266K | 0.54% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 261K | 0.53% | +0.23% | Oct 2026 |
| Fidelity Extended Market Index | 233K | 0.48% | -2.38% | Sep 2026 |
| Vanguard Tax-Managed Small Cap Adm | 227K | 0.46% | 0.00% | Sep 2026 |
Top institutions holding NHI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 8.73M | 17.78% | +81.68% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 4.63M | 9.43% | +11.79% | Jun 2026 |
| State Street Corp | 2.74M | 5.57% | +38.57% | Jun 2026 |
| Vanguard Capital Management, LLC | 2.10M | 4.27% | +0.70% | Jun 2026 |
| Principal Financial Group Inc | 2.00M | 4.07% | +1.04% | Sep 2026 |
| Bank of New York Mellon Corp | 1.61M | 3.27% | +212.10% | Jun 2026 |
| Geode Capital Management, LLC | 1.40M | 2.86% | +6.98% | Jun 2026 |
| Bank of America Corp | 1.02M | 2.08% | +2.68% | Jun 2026 |
| Charles Schwab Investment Management Inc | 880K | 1.79% | +6.58% | Jun 2026 |
| Delaware Management Holdings Inc | 870K | 1.77% | -3.00% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 688K | 1.40% | +1.83% | Sep 2026 |
| NORGES BANK | 672K | 1.37% | -7.15% | Jun 2026 |
| Northern Trust Corp | 609K | 1.24% | +8.14% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 444K | 0.90% | +16.89% | Jun 2026 |
| JPMorgan Chase & Co | 415K | 0.85% | -57.89% | Jun 2026 |
| UBS Group AG | 396K | 0.81% | +210.44% | Jun 2026 |
| Two Sigma Investments LLC | 335K | 0.68% | -20.15% | Jun 2026 |
| GW&K Investment Management, LLC | 323K | 0.66% | -3.73% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 321K | 0.65% | +2.98% | Jun 2026 |
| Legal & General Group PLC | 285K | 0.58% | +23.04% | Jun 2026 |
National Health Investors Inc company profile
- Company name
- National Health Investors Inc
- Ticker
- NHI.US
- Exchange
- USA Stocks
- Listed since
- Oct 9, 1991
- Sector
- Real Estate
- Industry
- Diversified REITs
- Employees
- 32
- Fiscal year end
- December
- Address
- 222 Robert Rose Drive, Murfreesboro, TN, United States, 37129-6346
- Phone
- 615 890 9100
- Website
- nhireit.com
About National Health Investors Inc
National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company's real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities and hospitals. National Health Investors, Inc. was established on October 15th, 1991, and was incorporated in 1991 in Maryland and is based in Murfreesboro, Tennessee.
National Health Investors Inc management
10- Mr. D. Eric MendelsohnPresident, CEO & Director · born 1962
- Mr. Kevin Carlton PascoeExecutive VP of Investments & Chief Investment Officer · born 1981
- Mr. David Louis TravisSenior VP & Chief Accounting Officer · born 1975
- Ms. Kristin Sallee GainesSenior VP & Chief Transaction Officer · born 1972
- Mr. Todd M. SiefertChief Financial Officer
- Mr. Christian K.S. MaingotEVP & Chief Operating Officer
- Mr. Dana Rolfson HamblySenior Vice President of Finance & Investor Relations
- Mr. Kimberly OuimetDirector of Corporate Compliance & Human Resources
- Ms. Beth J. BlankenshipSenior Vice President of Legal Affairs & Corporate Secretary · born 1970
- Mr. Grant JohnstonSenior Vice President Asset Management